HAART in HIV-infected patients: Restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia

AIDS

Volumn 13, Issue 14, 1999, Pages 1857-1862

  Wendland, Thomas ^a   Furrer, Hansjakob ^a   Vernazza, Pietro L ^b   Frutig, Karin ^a   Christen, Anna ^a   Matter, Lukas ^a   Malinverni, Raffaele ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

CD4; Cellular immunity; Combination therapy; Delayed type hypersensitivity; Opportunistic infections

Indexed keywords

ANTIRETROVIRUS AGENT; CANDIDA ANTIGEN; CD4 ANTIGEN; MYCOBACTERIUM ANTIGEN; PROTEINASE INHIBITOR; TETANUS TOXOID; VIRUS RNA;

ADULT; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MONONUCLEAR CELL; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VIREMIA;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DRUG THERAPY, COMBINATION; FEMALE; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; VIRAL LOAD; VIREMIA;

EID: 0032732511     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910010-00007     Document Type: Article

References (17)

1. Perelson AS, Essunger P, Ho DD. Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 1997, 11 (suppl A):S17-S24.
2. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985, 313:79-84.
3. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989, 84:1892-1899.
4. Dolan MJ, Clerici M, Blatt SP, et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995, 172:79-87.
5. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med 1996, 334:1011-1017.
6. Autran B, Carcelain C, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
7. Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
8. Furrer HJ, Wendland T, Minder C, et al. Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics. AIDS 1998, 12:1341-1346.
9. Ledermann MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of aids clinical trials group protocol 315. J Infect Dis 1998, 178:70-79.
10. Littman DR. Chemokine receptors: keys to AIDS pathogenesis? Cell 1998, 93:677-680.
11. Gorochov G, Neumann AU, Kereveur A, et al. Pertubation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nature Med 1998, 4:215-221.
12. Waldrop SL; Pitcher CJ; Peterson DM; Maino VC; Picker LJ. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997, 99:1739-1750.
13. Komanduri KV, Viswanathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active anti-retroviral therapy in individuals infected with HIV-1. Nature Med 1998, 4:953-956.
14. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997, 315:1194-1199.
15. Furrer HJ, Egger M, Opravil M et al. and the Swiss HIV Cohort Study. Discontinuation of primary prophylaxis against pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. N Engl J Med 1999, 340:1301-1306.
16. Schneider MME, Borleffs JCC, Stolk RP, Jaspers AJJ, Hoepelman AIM. Discontinuation of prophylaxis for pneumocystis carinii pneumonia in HIV-1 infected patients treated with highly active antiretroviral therapy. Lancet 1999, 353:201-203.
17. Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998, 177:1182-1187.